These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34281539)

  • 1. METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis.
    Jiang Z; Yin W; Zhu H; Tan J; Guo Y; Xin Z; Zhou Q; Cao Y; Wu Z; Kuang Y; Li C; Xie D; Huang H; Zhao M; Jiang X; Wang L; Ren C
    Cancer Cell Int; 2021 Jul; 21(1):383. PubMed ID: 34281539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Potential of METTL7B in Glioma.
    Fu R; Luo X; Ding Y; Guo S
    Neuroimmunomodulation; 2022; 29(3):186-201. PubMed ID: 35034026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in Glioma.
    Chen X; Li C; Li Y; Wu S; Liu W; Lin T; Li M; Weng Y; Lin W; Qiu S
    Front Mol Biosci; 2021; 8():727481. PubMed ID: 34604305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma.
    Xiong Y; Li M; Bai J; Sheng Y; Zhang Y
    Front Oncol; 2021; 11():650534. PubMed ID: 33996568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL7B (methyltransferase-like 7B) identification as a novel biomarker for lung adenocarcinoma.
    Ali J; Liu W; Duan W; Liu C; Song J; Ali S; Li E; Wang Q
    Ann Transl Med; 2020 Sep; 8(18):1130. PubMed ID: 33240979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL7B serves as a prognostic biomarker and promotes metastasis of lung adenocarcinoma cells.
    Li R; Mu C; Cao Y; Fan Y
    Ann Transl Med; 2022 Aug; 10(16):895. PubMed ID: 36110989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SERPINH1 is a Potential Prognostic Biomarker and Correlated With Immune Infiltration: A Pan-Cancer Analysis.
    Wang Y; Gu W; Wen W; Zhang X
    Front Genet; 2021; 12():756094. PubMed ID: 35058967
    [No Abstract]   [Full Text] [Related]  

  • 8. METTL7B promotes migration and invasion in thyroid cancer through epithelial-mesenchymal transition.
    Ye D; Jiang Y; Sun Y; Li Y; Cai Y; Wang Q; Wang O; Chen E; Zhang X
    J Mol Endocrinol; 2019 Jul; 63(1):51-61. PubMed ID: 31121562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis.
    Ju Q; Li X; Zhang H; Yan S; Li Y; Zhao Y
    Oxid Med Cell Longev; 2020; 2020():3580719. PubMed ID: 33101586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Whole Exon Screening-Based Score Model Predicts Prognosis and Immune Checkpoint Inhibitor Therapy Effects in Low-Grade Glioma.
    Luo C; Wang S; Shan W; Liao W; Zhang S; Wang Y; Xin Q; Yang T; Hu S; Xie W; Xu N; Zhang Y
    Front Immunol; 2022; 13():909189. PubMed ID: 35769464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of METTL7B Inhibits Proliferation of Human Clear Cell Renal Cancer Cells
    Li W; Xu S; Peng N; Zhang Z; He H; Chen R; Chen D; Fan J; Wang X
    Front Oncol; 2021; 11():634542. PubMed ID: 33718220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Potential of Secreted Modular Calcium-Binding Protein 1 in Low-Grade Glioma.
    Wang J; Xia S; Zhao J; Gong C; Xi Q; Sun W
    Front Mol Biosci; 2021; 8():666623. PubMed ID: 34869577
    [No Abstract]   [Full Text] [Related]  

  • 13. Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint.
    Bai KH; Zhang YY; Li XP; Tian XP; Pan MM; Wang DW; Dai YJ
    Comput Struct Biotechnol J; 2022; 20():5226-5234. PubMed ID: 36187930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma.
    Liu J; Li W; Wu L
    Front Pharmacol; 2022; 13():950156. PubMed ID: 36046831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNIH4: a novel biomarker connected with poor prognosis and cell proliferation in patients with lower-grade glioma.
    Xiao F; Sun G; Zhu H; Guo Y; Xu F; Hu G; Huang K; Guo H
    Am J Cancer Res; 2023; 13(5):2135-2154. PubMed ID: 37293170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma.
    Tan Z; Zhang Z; Yu K; Yang H; Liang H; Lu T; Ji Y; Chen J; He W; Chen Z; Mei Y; Shen XL
    Front Neurol; 2022; 13():964590. PubMed ID: 36388191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma.
    Xiao Y; Cui G; Ren X; Hao J; Zhang Y; Yang X; Wang Z; Zhu X; Wang H; Hao C; Duan H
    Front Oncol; 2020; 10():605737. PubMed ID: 33381460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FCGR3A Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lower-Grade Glioma.
    Sun K; Fei X; Xu M; Xu R; Xu M
    J Oncol; 2022; 2022():9499317. PubMed ID: 39280892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of ZFP36L2 correlates with the prognosis and immune infiltration in lower-grade glioma.
    Zhou M; Li J; Chen C
    Front Genet; 2022; 13():914219. PubMed ID: 35910229
    [No Abstract]   [Full Text] [Related]  

  • 20. NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma.
    Ren W; Yang S; Chen X; Guo J; Zhao H; Yang R; Nie Z; Ding L; Zhang L
    Front Oncol; 2022; 12():918606. PubMed ID: 35898895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.